Sort
51,593 grants matching “hepatitis”
Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study
$2,588,461Linda A Teplin · Northwestern University At Chicago · R01 · FY2012 · DA
Case Clinical Trials Unit
$2,582,654Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2022 · AI
Solid Organ Transplantation in HIV: Multi-Site Study
$2,581,879Peter G Stock · University Of California, San Francisco · U01 · FY2009 · AI
Epidemiology and Natural History of Cancer-Associated Viruses
$2,581,642Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
CPCRA Clinical Trials Unit
$2,581,220Fred M Gordin · George Washington University · U01 · FY2007 · AI
Southern Liver Health Cohort
$2,579,511Cathrine Hoyo · North Carolina State University Raleigh · UH3 · FY2024 · CA
University of Washington Vaccine and Treatment Evaluation Unit
$2,579,381Anna Wald · University Of Washington · UM1 · FY2024 · AI
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,577,612David W Haas · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Case Clinical Trials Unit
$2,575,678Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2021 · AI
RADx Innovation Funnel for Hepatitis B Diagnostics â Commercialization Center
$2,574,898Mark Marino · Venturewell · N02 · FY2025 · HL
Toward Safer Gene Therapy for Hemophilia A
$2,572,180Roland W. Herzog · Indiana University Indianapolis · P01 · FY2022 · HL
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,568,667Andrea L Cox · Johns Hopkins University · U19 · FY2025 · AI
Sexually Transmitted Infections Clinical Trials Group
$2,564,303Giudice Linda · University Of California, San Francisco · N01 · FY2017 · AI
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM
$2,563,314Judy Lieberman · Immune Disease Institute, Inc. · U19 · FY2006 · AI
Vascular remodeling in patients with rare genetic disorders
$2,562,680Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM
$2,556,273Judy Lieberman · Immune Disease Institute, Inc. · U19 · FY2007 · AI
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM
$2,556,265Immune Disease Institute, Inc. · U19 · FY2005 · AI
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,554,475Shruti H Mehta · Johns Hopkins University · U01 · FY2019 · DA
Case Clinical Trials Unit
$2,553,716Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2016 · AI
Chicago Consortium Women's Interagency HIV Study lll
$2,553,501Hektoen Institute For Medical Research · U01 · FY2003 · AI
Case AIDS Clinical Trials Unit
$2,550,636Michael Marcel Lederman · Case Western Reserve University · U01 · FY2008 · AI
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
$2,550,443Mark Thomas Gladwin · University Of Maryland Baltimore · UH3 · FY2024 · HL
Role of G protein-coupled receptors in regulating glucose and energy homeostasis
$2,548,984Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Stroke with Transfusions Changing to Hydroxyurea
$2,545,955Russell E Ware · St. Jude Children'S Research Hospital · U01 · FY2009 · HL
Factors which predict variance in weight change
$2,544,652Jonathan Krakoff · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK